Fonseca, P. E. O.; Azevedo, J. A.; Bié, S. M. G.; Ferreira, S. B. Benefits of Using SLGT2 Inhibitors for Patients With CDK and DM2 to Reduce Mortality Risks. Arch Pharm Pharma Sci 2024, 8, 041-046.